Davide Brocco

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini et al. · The Oncologist · 2019 · 221 citations · Full text

Life Sciences, Immunology, Oncology +17

Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study

Alessio Cortellini, Federico Bozzetti, Pierpaolo Palumbo et al. · Scientific Reports · 2020 · 91 citations · Full text

Medicine, Oncology, Radiology +17

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A “hypothesis‐generator” preliminary report

Alessio Cortellini, Lucilla Verna, Giampiero Porzio et al. · Thoracic Cancer · 2019 · 65 citations · Full text

Medicine, Oncology, Radiology +17

Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

Davide Brocco, Paola Lanuti, Pasquale Simeone et al. · Journal of Oncology · 2019 · 55 citations · Full text

Medicine, Cell Biology, Oncology +17

Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors

Davide Brocco, Paola Lanuti, Damiana Pieragostino et al. · Cancers · 2021 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17